-
Immune Checkpoint Humanized Mice
- Biocytogen Humanized Immune-Checkpoint Mice
- B-hPD-1 mice
- B-hCD274(PD-L1) mice
- B-hCTLA4 mice
- B-hTNFRSF4(OX40) mice
- B-hCD137(4-1BB) mice
- B-hCD27 mice
- B-hHAVCR2 (TIM3) mice
- B-hCD3e mice(v1)
- B-hCD3e mice(v2)
- B-hSIRPA mice
- B-hCD47 mice
- B-hTIGIT mice
- B-hLAG3 mice
- B-hBTLA mice
- B-hCD28 mice
- B-hCD40 mice
- B-hTNFRSF18(GITR) mice
- B-hCD47(B/c) mice
- B-hPD-1/hOX40 mice
- B-hPD-1/hPD-L1 mice
- B-hPD-1/hTIGIT mice
- B-hPD-1/hTIM3 mice
- B-hPD-1/hBTLA mice
- B-hPD-1/h4-1BB mice
- B-hPD-1/hLAG3 mice
- B-hPD-1/hCD27mice
- B-hPD-1/hCTLA4 mice
- B-hSIRPA/hCD47 mice
- Recent advances in drug research
Contact Us
- 1Innovation Drive
- Biotech. 3, Suite 430
- Worcester MA 01605
- USA
Recent advances in drug research
2017-05-09 17:39:26.0
Anti-PD-1 drug research and development status
Anti-PD-L1 drug research and development status
Immune checkpoint drug research and development status
